Polar Capital Holdings’s Neuropace NPCE Stock Holding History

Polar Capital Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.4M	Hold	3,298,104	–	–	0.12%	120
2026 Q1	$43.4M	Buy	3,298,104 +419,581	+15%	+$6.29M	0.15%	110
2025 Q4	$44.4M	Sell	2,878,523 -219,345	-7%	-$2.93M	0.17%	105
2025 Q3	$31.9M	Buy	+3,097,868	New	+$29.2M	0.15%	112
2025 Q2	–	Sell	-2,972,003	Closed	-$37.2M	–	297
2025 Q1	$36.5M	Buy	+2,972,003	New	+$37.2M	0.22%	113

Other funds holding NPCE

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polar Capital Holdings's NPCE Position: Q2 2026 in Review

Polar Capital Holdings held its Neuropace (NPCE) position steady in Q2 2026 at 3,298,104 shares worth $52.4M. The position accounts for 0.12% of the portfolio, ranked #120.

Polar Capital Holdings first reported a position in NPCE in Q1 2025 and has held it in 5 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

Polar Capital Holdings held 3,298,104 shares of Neuropace worth $52.4M as of Q2 2026.
Polar Capital Holdings left its Neuropace share count unchanged in Q2 2026.
Neuropace made up 0.12% of Polar Capital Holdings's portfolio in Q2 2026, its #120 holding.
Polar Capital Holdings first reported a position in Neuropace in Q1 2025 and has held it in 5 quarters since.
113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.